Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” ...

CLSA said that even if tariffs are imposed, Indian drug makers are likely to pass on the costs, given their dominant market ...

Experts warn that U.S. reciprocal tariffs on Indian goods could impact various sectors, including agriculture, pharma, and ...

"Ceramic, glass, and stone products, with USD 1.71 billion in exports, will face an 8.27 per cent tariff, impacting demand.

As per an analysis of the GTRI, the hardest-hit sector in agriculture would be fish, meat, and processed seafood, with $2.58 ...

Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an 8 percent compound annual growth rate (CAGR) over FY15-24.

The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the ...

Trump imposed a 10% tariff on most U.S. imports, as well as much higher levies on dozens of rivals and allies alike, but ...

GROUPE LSL PHARMA INC (TSXV: LSL) (TSXV: LSL.DB) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical ...

The BRS MP on Thursday thanked Prime Minister Narendra Modi for his intervention on the issue. He wrote a letter to the Prime ...